Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

A tumor necrosis factor binding protein is present in human biological fluids

Peetre, Christina ; Thysell, Hans LU ; Grubb, A LU orcid and Olsson, Inge LU (1988) In European Journal of Haematology 41(5). p.414-419
Abstract

Tumor necrosis factor (TNF) possesses both beneficial and toxic bioactivities. Mechanisms may operate to counteract harmful effects. We have identified a TNF binding protein (TNF-BP), which shows increased levels in serum and urine of patients on regular hemodialysis treatment (RDT). TNF-BP inhibited the specific binding of human recombinant TNF (rTNF) to its cell surface receptor. Results from gel chromatography demonstrated the presence in serum and urine of a macromolecule with an apparent molecular weight of 50,000, which formed a complex with rTNF. A 62-fold purification of TNF-BP from urine of patients on RDT was achieved by ion exchange chromatography and gel chromatography. Partially purified TNF-BP reduced the growth inhibitory... (More)

Tumor necrosis factor (TNF) possesses both beneficial and toxic bioactivities. Mechanisms may operate to counteract harmful effects. We have identified a TNF binding protein (TNF-BP), which shows increased levels in serum and urine of patients on regular hemodialysis treatment (RDT). TNF-BP inhibited the specific binding of human recombinant TNF (rTNF) to its cell surface receptor. Results from gel chromatography demonstrated the presence in serum and urine of a macromolecule with an apparent molecular weight of 50,000, which formed a complex with rTNF. A 62-fold purification of TNF-BP from urine of patients on RDT was achieved by ion exchange chromatography and gel chromatography. Partially purified TNF-BP reduced the growth inhibitory effect of rTNF on a susceptible leukemia cell line. TNF-BP may act as a regulator of the biological activity of TNF and could have beneficial effects in certain inflammatory conditions.

(Less)
Please use this url to cite or link to this publication:
author
; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Binding, Competitive, Chromatography, Gel, Chromatography, Ion Exchange, Humans, Kidney Diseases/blood, Protein Binding, Receptors, Cell Surface/isolation & purification, Recombinant Proteins/metabolism, Renal Dialysis, Tumor Cells, Cultured/drug effects, Tumor Necrosis Factor-alpha/antagonists & inhibitors
in
European Journal of Haematology
volume
41
issue
5
pages
414 - 419
publisher
Wiley-Blackwell
external identifiers
  • scopus:0024214443
  • pmid:2850215
ISSN
0902-4441
DOI
10.1111/j.1600-0609.1988.tb00220.x
language
English
LU publication?
yes
id
6691d36e-c7c6-481a-9b24-68cdb5efe461
date added to LUP
2021-10-27 08:23:53
date last changed
2024-01-12 02:54:29
@article{6691d36e-c7c6-481a-9b24-68cdb5efe461,
  abstract     = {{<p>Tumor necrosis factor (TNF) possesses both beneficial and toxic bioactivities. Mechanisms may operate to counteract harmful effects. We have identified a TNF binding protein (TNF-BP), which shows increased levels in serum and urine of patients on regular hemodialysis treatment (RDT). TNF-BP inhibited the specific binding of human recombinant TNF (rTNF) to its cell surface receptor. Results from gel chromatography demonstrated the presence in serum and urine of a macromolecule with an apparent molecular weight of 50,000, which formed a complex with rTNF. A 62-fold purification of TNF-BP from urine of patients on RDT was achieved by ion exchange chromatography and gel chromatography. Partially purified TNF-BP reduced the growth inhibitory effect of rTNF on a susceptible leukemia cell line. TNF-BP may act as a regulator of the biological activity of TNF and could have beneficial effects in certain inflammatory conditions.</p>}},
  author       = {{Peetre, Christina and Thysell, Hans and Grubb, A and Olsson, Inge}},
  issn         = {{0902-4441}},
  keywords     = {{Binding, Competitive; Chromatography, Gel; Chromatography, Ion Exchange; Humans; Kidney Diseases/blood; Protein Binding; Receptors, Cell Surface/isolation & purification; Recombinant Proteins/metabolism; Renal Dialysis; Tumor Cells, Cultured/drug effects; Tumor Necrosis Factor-alpha/antagonists & inhibitors}},
  language     = {{eng}},
  number       = {{5}},
  pages        = {{414--419}},
  publisher    = {{Wiley-Blackwell}},
  series       = {{European Journal of Haematology}},
  title        = {{A tumor necrosis factor binding protein is present in human biological fluids}},
  url          = {{http://dx.doi.org/10.1111/j.1600-0609.1988.tb00220.x}},
  doi          = {{10.1111/j.1600-0609.1988.tb00220.x}},
  volume       = {{41}},
  year         = {{1988}},
}